Fpr2^-/- Mice Developed Exacerbated Alcohol-Associated Liver Disease

Area of Science:

• Hepatology
• Immunology
• Molecular Biology

Background:

• Alcohol-associated liver disease (ALD) is a prevalent chronic liver condition with substantial healthcare implications.
• Current treatment for ALD is limited to abstinence, and its underlying pathogenic mechanisms remain incompletely understood.
• Formyl peptide receptor 2 (FPR2), a known receptor for immunomodulatory signals, has not been extensively studied in the context of ALD.

Purpose of the Study:

• To investigate the role of formyl peptide receptor 2 (FPR2) in the pathogenesis of alcohol-associated liver disease (ALD).
• To elucidate the impact of FPR2 deficiency on liver injury, inflammation, and regeneration following chronic ethanol exposure.

Main Methods:

• Utilized wild-type (WT) and Fpr2 knockout (Fpr2^-/-) mouse models.
• Administered chronic-binge ethanol exposure to mice.
• Assessed liver injury, inflammation, regeneration markers, macrophage differentiation, and neutrophil oxidative burst activity.

Main Results:

• Fpr2^-/- mice exhibited more severe liver injury and inflammation compared to WT mice after ethanol administration.
• Liver regeneration was compromised in Fpr2^-/- mice.
• Hepatic monocyte-derived restorative macrophages were reduced in Fpr2^-/- mice, and their neutrophils showed diminished oxidative burst capacity.

Conclusions:

• Loss of FPR2 exacerbates liver damage in ALD through multiple mechanisms, including dysregulated immune responses.
• FPR2 is critical for maintaining normal immune cell function and promoting liver repair in the context of alcohol-induced liver injury.
• These findings highlight FPR2 as a potential therapeutic target for managing alcohol-associated liver disease.